Truist Financial Corp Fulgent Genetics, Inc. Transaction History

Truist Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$23.64 - $30.27 $8,392 - $10,745	-355 Reduced 3.13%	10,991 $317,000
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $30,055 - $45,870	1,124 Added 11.0%	11,346 $303,000
Q2 2023 Aug 01, 2023	SELL	$28.52 - $40.7 $85,959 - $122,669	-3,014 Reduced 22.77%	10,222 $378,000
Q4 2022 Feb 17, 2023	BUY	$29.23 - $40.28 $386,888 - $533,146	13,236 New	13,236 $394,000
Q2 2022 Jul 22, 2022	SELL	$47.98 - $62.75 $742,922 - $971,621	-15,484 Reduced 68.35%	7,170 $391,000
Q1 2022 Apr 22, 2022	BUY	$49.85 - $96.11 $124,126 - $239,313	2,490 Added 12.35%	22,654 $1.41 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $1,159 - $1,575	-15 Reduced 0.07%	20,164 $2.03 Million
Q3 2021 Nov 05, 2021	BUY	$74.87 - $110.87 $1.18 Million - $1.75 Million	15,756 Added 356.23%	20,179 $1.82 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $295,456 - $444,290	4,423 New	4,423 $408,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.